Evidence map›Paper›PMID 36555591›Full record

ArticleInternational journal of molecular sciences2022

Effects of MgSO

Lou Legouez, Bérénice Le Dieu-Lugon, Shérine Feillet, Gaëtan Riou, Melissa Yeddou, Thibault Plouchart, Nathalie Dourmap, Marie-Anne Le Ray, Stéphane Marret, Bruno J Gonzalez and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lou LegouezINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Bérénice Le Dieu-LugonINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Shérine FeilletINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Gaëtan RiouINSERM U1234 "Pan'Ther", Flow Cytometry Core-IRIB, 76000 Rouen, France.
Melissa YeddouINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Thibault PlouchartINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Nathalie DourmapINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Marie-Anne Le RayINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Stéphane MarretINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.ORCID 0000-0002-2858-148X
Bruno J GonzalezINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Carine ClerenINSERM U1245 "Cancer and Brain Genomics"-Team "Genetics and Pathophysiology of Neurodevelopmental Disorders", IRIB, 76000 Rouen, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral palsy (CP) is defined as permanent disorders of movement and posture. Prematurity and hypoxia-ischemia (HI) are risk factors of CP, and boys display a greater vulnerability to develop CP. Magnesium sulfate (MgSO

Indexed as

Cerebral PalsyHypoxia-Ischemia, BrainNeuroprotective AgentsWhite MatterAnimalsAnimals, NewbornButylaminesFemaleMagnesium SulfateMaleMice4-phenylbutylamineButylaminesMagnesium SulfateNeuroprotective Agents4-phenylbutyratebehaviorhypoxic–ischemic lesionmagnesium sulfatesexwhite matter oligodendrocyte differentiation

Identifiers

PMID36555591
PMCPMC9788405
OpenAlexW4311515788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.